Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy

Millions of individuals who have recovered from SARS-CoV-2 infection may be eligible to participate in convalescent plasma donor programs, yet the optimal window for donating high neutralizing titer convalescent plasma for COVID-19 immunotherapy remains unknown. Here we studied the response trajecto...

Descripción completa

Detalles Bibliográficos
Autores principales: Gontu, Abhinay, Srinivasan, Sreenidhi, Salazar, Eric, Nair, Meera Surendran, Nissly, Ruth H., Greenawalt, Denver, Bird, Ian M., Herzog, Catherine M., Ferrari, Matthew J., Poojary, Indira, Katani, Robab, Lindner, Scott E., Minns, Allen M., Rossi, Randall, Christensen, Paul A., Castillo, Brian, Chen, Jian, Eagar, Todd N., Yi, Xin, Zhao, Picheng, Leveque, Christopher, Olsen, Randall J., Bernard, David W., Gollihar, Jimmy, Kuchipudi, Suresh V., Musser, James M., Kapur, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904946/
https://www.ncbi.nlm.nih.gov/pubmed/33627795
http://dx.doi.org/10.1038/s42003-021-01813-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904946/
https://www.ncbi.nlm.nih.gov/pubmed/33627795
http://dx.doi.org/10.1038/s42003-021-01813-y

Ejemplares similares